Issue 12, 2010

Effects of the confluence rate on the FTIR spectrum of PC-3 prostate cancer cells in culture

Abstract

Recently, the possibility of using IR spectroscopy to fingerprint the mode of action of potent antitumor drugs on cancer cells at sub-lethal concentrations has been demonstrated by comparing spectra recorded from untreated or drug-treated cells. The present study investigates the potential interference of the cell culture confluence rate on cell FTIR signature. Significant spectral differences were observed on cells harvested at different confluence rates. Yet, these differences were weak when compared to those induced by sub-lethal ouabain concentrations, used as a model of cardenolide drug. Furthermore, principal component analysis reveals that the impact of the confluence rate, above 50% coverage, on the FTIR spectra is essentially unique and orthogonal to the one induced by the drug model.

Graphical abstract: Effects of the confluence rate on the FTIR spectrum of PC-3 prostate cancer cells in culture

Article information

Article type
Paper
Submitted
25 Jun 2010
Accepted
12 Aug 2010
First published
27 Sep 2010

Analyst, 2010,135, 3048-3051

Effects of the confluence rate on the FTIR spectrum of PC-3 prostate cancer cells in culture

R. Gasper and E. Goormaghtigh, Analyst, 2010, 135, 3048 DOI: 10.1039/C0AN00443J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements